US orders 10 million more courses of Pfizer’s COVID-19 antiviral

(By Erica Carbajal for Becker’s Hospital Review)

The U.S. is purchasing an additional 10 million courses of Paxlovid, Pfizer’s COVID-19 antiviral, the drugmaker said Jan. 4. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org